We are live on ! Find out more
DCI

Data Collective IV Portfolio holdings

AUM $55.9M
1-Year Est. Return 49.14%
This Fund
S&P 500
This Quarter Est. Return
+1.18%
1 Year Est. Return
+49.14%
3 Year Est. Return
+250.98%
5 Year Est. Return
10 Year Est. Return
AUM
$93.8M
AUM Growth
-$1.38M
Cap. Flow
-$181K
Cap. Flow %
-0.19%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
2
Closed

Top Buys

No buys this quarter

Sector Composition

Rank Sector Weight
1 Industrials 47.86%
2 Healthcare 42.6%
3 Technology 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXRX icon
1
Recursion Pharmaceuticals
RXRX
$1.62B
$39.6M 42.23%
5,941,120
EVLV icon
2
Evolv Technologies
EVLV
$1.01B
$33.1M 35.25%
10,601,281
RKLB icon
3
Rocket Lab Corp
RKLB
$39.9B
$11.8M 12.61%
2,929,350
EMBK
4
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$8.95M 9.54%
3,186,007
-1
-0% -$4
DFTX
5
Definium Therapeutics
DFTX
$5.57B
$318K 0.34%
100,350
ROIV icon
6
Roivant Sciences
ROIV
$24.3B
$28.6K 0.03%
3,875
-21,965
-85% -$181K

Similar funds

Data Collective IV's Q1 2023 Portfolio in Review

As of Q1 2023, Data Collective IV held 6 positions worth $93.8M, down 1.4% from $95.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 0%. Data Collective IV opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 48% of assets, up from 40% a quarter earlier, followed by Healthcare and Technology.

  • Data Collective IV's biggest Q1 2023 reduction was Roivant Sciences, cutting an estimated $181K.
  • Data Collective IV's ten largest holdings make up 100% of its $93.8M portfolio in Q1 2023.
  • Data Collective IV opened 0 new positions and closed 0 in Q1 2023.
  • Data Collective IV's portfolio value fell 1.4% quarter-over-quarter to $93.8M.

Based on Data Collective IV's 13F filing for Q1 2023, filed 15 May 2023.